These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1855803)

  • 1. A qualitative approach to cell growth modeling and simulation for cancer chemotherapy.
    Gaglio S; Giacomini M; Nicolini C; Ruggiero C
    IEEE Trans Biomed Eng; 1991 Apr; 38(4):386-9. PubMed ID: 1855803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling multi-drug chemotherapy: tailoring treatment to individuals.
    Gardner SN
    J Theor Biol; 2002 Jan; 214(2):181-207. PubMed ID: 11812172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy may be delivered based on an integrated view of tumour dynamics.
    Ribba B; You B; Tod M; Girard P; Tranchand B; Trillet-Lenoir V; Freyer G
    IET Syst Biol; 2009 May; 3(3):180-90. PubMed ID: 19449978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel combination chemotherapy integrating with intratumoral chemotherapy.
    Yang L; Wang B; Qiao W; Liu P
    Med Hypotheses; 2009 Sep; 73(3):334-5. PubMed ID: 19423239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A step toward optimization of cancer therapeutics. Physiologically based modeling of circadian control on cell proliferation.
    Clairambault J
    IEEE Eng Med Biol Mag; 2008; 27(1):20-4. PubMed ID: 18270046
    [No Abstract]   [Full Text] [Related]  

  • 6. Modelling and simulation of chemotherapy of haematological and gynaecological cancers.
    Nani FK; Oğuztöreli MN
    IMA J Math Appl Med Biol; 1999 Mar; 16(1):39-91. PubMed ID: 10335600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy.
    Murray JM
    IMA J Math Appl Med Biol; 1997 Dec; 14(4):283-303. PubMed ID: 9415996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular effects of cancer chemotherapy administration.
    Moran P
    J Intraven Nurs; 2000; 23(1):44-51. PubMed ID: 11013533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making sense of cancer chemotherapy.
    Holmes S
    Nurs Times; 1996 Sep 4-10; 92(36):42-3. PubMed ID: 8868768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic modeling of drug resistance in cancer.
    Komarova N
    J Theor Biol; 2006 Apr; 239(3):351-66. PubMed ID: 16194548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated network-based mechanistic model for tumor growth dynamics under drug administration.
    Ribeiro D; Pinto JM
    Comput Biol Med; 2009 Apr; 39(4):368-84. PubMed ID: 19285661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some drug-resistant models for cancer chemotherapy. Part 1: Cycle-nonspecific drugs.
    Usher JR; Henderson D
    IMA J Math Appl Med Biol; 1996 Jun; 13(2):99-126. PubMed ID: 8671582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting cancer cell cycling for selective protection of normal cells.
    Blagosklonny MV; Pardee AB
    Cancer Res; 2001 Jun; 61(11):4301-5. PubMed ID: 11389048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General principles of cancer chemotherapy].
    Orzechowska-Juzwenko K
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1675-8. PubMed ID: 6679091
    [No Abstract]   [Full Text] [Related]  

  • 15. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
    Chen Z; Koeneman KS; Corey DR
    Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells.
    Barbarossa MV; Kuttler C; Zinsl J
    Math Biosci Eng; 2012 Apr; 9(2):241-57. PubMed ID: 22901063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing drug regimens in cancer chemotherapy by an efficacy-toxicity mathematical model.
    Iliadis A; Barbolosi D
    Comput Biomed Res; 2000 Jun; 33(3):211-26. PubMed ID: 10860586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dynamics of cell proliferation.
    Moxnes JF; Haux J; Hausken K
    Med Hypotheses; 2004; 62(4):556-63. PubMed ID: 15050107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents.
    Ribba B; Saut O; Colin T; Bresch D; Grenier E; Boissel JP
    J Theor Biol; 2006 Dec; 243(4):532-41. PubMed ID: 16930628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling chemotherapy resistance in palliation and failed cure.
    Monro HC; Gaffney EA
    J Theor Biol; 2009 Mar; 257(2):292-302. PubMed ID: 19135065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.